May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
C3 Variant Is Associated With Neovascular AMD & Geographic Atrophy in Age-Related Macular Degeneration
Author Affiliations & Notes
  • L. J. Kopplin
    Case Western Reserve University, Cleveland, Ohio
    Genetics,
  • Y. Wang
    Case Western Reserve University, Cleveland, Ohio
    Epidemiology and Biostatistics,
  • S. Ajudua
    Brown University, Providence, Rhode Island
  • R. P. Igo, Jr.
    Case Western Reserve University, Cleveland, Ohio
    Epidemiology and Biostatistics,
  • E. Y. Chew
    NEI-NIH, Bethesda, Maryland
  • T. E. Clemons
    EMMES Corp., Rockville, Maryland
  • A. K. Henning
    EMMES Corp., Rockville, Maryland
  • P. J. Francis
    Casey Eye Institute, OHSU, Portland, Oregon
  • M. L. Klein
    Casey Eye Institute, OHSU, Portland, Oregon
  • S. K. Iyengar
    Case Western Reserve University, Cleveland, Ohio
    Genetics,
    Epidemiology and Biostatistics,
  • Footnotes
    Commercial Relationships  L.J. Kopplin, None; Y. Wang, None; S. Ajudua, None; R.P. Igo, None; E.Y. Chew, None; T.E. Clemons, None; A.K. Henning, None; P.J. Francis, None; M.L. Klein, None; S.K. Iyengar, None.
  • Footnotes
    Support  R01EY 015810 to SKI, N0-EY-0-2127 to EYC, TEC, AKH, JPSG
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2669. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. J. Kopplin, Y. Wang, S. Ajudua, R. P. Igo, Jr., E. Y. Chew, T. E. Clemons, A. K. Henning, P. J. Francis, M. L. Klein, S. K. Iyengar; C3 Variant Is Associated With Neovascular AMD & Geographic Atrophy in Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2669. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine whether common variants of complement component 3 (C3) gene are associated with neovascular (NV) AMD and geographic atrophy (GA) after considering the impact of variants in other AMD-associated genes, age, and smoking.

Methods: : We applied data from 557 participants of the Age-Related Eye Disease Study (AREDS) who were self-identified as white, not of Hispanic origin to examine the distribution of ten C3 variants as they may relate to advanced AMD; our sample contained 184 AMD-free people, 131 people with GA, 194 people with NV AMD, and 48 people with GA + NV AMD. Primary outcomes (GA, NV AMD, or NV AMD and/or GA) were ascertained prospectively with a standardized method by masked professional graders from color fundus photographs collected annually across a 12 year period. Our comparison group contained people who remained AMD-free across the course of the study.

Results: : Arg102Gly of exon 3 was the only C3 variant associated with advanced AMD in models adjusted for age, smoking history, and other AMD-associated SNPs. The likelihood of having pure NV AMD was increased more than 2-fold among people carrying one or two risk alleles of Arg102Gly; respective odds ratios (OR) are 2.6 (95% CI, 1.6-4.2, P ≤ 0.00007) and 3.1 (95% CI, 1.3-7.6, P ≤ 0.013). The magnitude of relationship was similar for GA. For people with a single risk allele OR=2.1 (95%CI, 1.3-3.6, P ≤ 0.004); for people homozygous for the risk allele OR=2.7 (95% CI, 0.98--7.7, P ≤ 0.06). Additive models yielded the following results: (1) for NV AMD OR=2.1 (95% CI, 1.5-3.1, P ≤ 0.00004); for GA OR=1.9 (95%CI, 1.3-2.8, P ≤ 0.002).

Conclusions: : A common functional variant in the complement component 3 gene (Arg102Gly, rs2230199) is associated both with NV AMD and GA after considering the impact of age, smoking, and known genetic risk factors. Our results support the idea that there is an inflammatory and immune-related basis of AMD pathogenesis. We are currently examining these relationships in independent populations.

Clinical Trial: : www.clinicaltrials.gov NCT00000145

Keywords: age-related macular degeneration • clinical (human) or epidemiologic studies: risk factor assessment • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×